HealthwoRx™ Now Offers CIMT Testing

More Sensitive than a Traditional Carotid Ultrasound

Predicting cardiovascular disease has a never been easier. The CIMT score, a NASA derived technology is now being offered to our patients in order to detect cardiovascular risk more accurately than traditional methods. A simple, painless, noninvasive, and relatively inexpensive, ultrasound is used to measure the thickness of the inner part of the carotid artery, the artery that leads to the brain. Those with higher carotid intima media thickness (CIMT) have a higher risk for developing significant cardiovascular disease such as heart attack, stroke, and peripheral vascular disease.

Serial monitoring tracks changes before a stroke occurs

CIMT ScreeningThis new, FDA approved procedure, is a more sensitive way of looking at the vascular tree than traditional carotid duplex ultrasound imaging. This powerful tool discovers atherosclerosis earlier, allowing your Healthworx physician and you, the patient, to modify risk factors before calamity strikes. Serial monitoring of your CIMT scores can track your progress, and alert your physician earlier if a change in your regimen is necessary.

Noninvasive, Fast, Safe and Inexpensive

This patented new technology, is now offered to you exclusively through the offices of your Healthworx physician. The cost of CIMT scoring is not covered by insurance, as most preventative screening is not reimbursed; however, because this is an important test than can prevent stroke, myocardial infarction, and peripheral vascular disease, Healthworx will be providing this service for only $199.00. Please call the Healthworx staff at 954.967.6550 and ask how you can obtain this important study and take charge to reduce your risk of having a debilitating cardiovascular event